Inhalations of Tranexamic Acid for hemoptysis: A randomized controlled trial

O. Wand (Kfar Saba, Israel), E. Guber (Kfar Saba, Israel), A. Guber (Kfar Saba, Israel), G. Epstein-Shochet (Kfar Saba, Israel), L. Israeli-Shani (Kfar Saba, Israel), D. Shitrit (Kfar Saba, Israel)

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4409

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Wand (Kfar Saba, Israel), E. Guber (Kfar Saba, Israel), A. Guber (Kfar Saba, Israel), G. Epstein-Shochet (Kfar Saba, Israel), L. Israeli-Shani (Kfar Saba, Israel), D. Shitrit (Kfar Saba, Israel). Inhalations of Tranexamic Acid for hemoptysis: A randomized controlled trial. 4409

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial
Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID
Year: 2021



Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

Utility of anticholinergic premedication for bronchoscopy: a randomized controlled trial
Source: Eur Respir J 2005; 26: Suppl. 49, 531s
Year: 2005

Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial)
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021


Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
Source: Eur Respir J, 59 (1) 2100752; 10.1183/13993003.00752-2021
Year: 2022



Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial
Source: Eur Respir J, 58 (4) 2002819; 10.1183/13993003.02819-2020
Year: 2021



Ambulatory management of secondary spontaneous pneumothorax: a randomised controlled trial
Source: Eur Respir J, 57 (6) 2003375; 10.1183/13993003.03375-2020
Year: 2021



Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Sedation for bronchoscopy in children: a prospective randomized double-blinded trial
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Tiotropium treatment for bronchiectasis (ROBUST): a randomized, placebo-controlled, crossover trial
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial.
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020




Budesonide versus prednisone in acute wheezing: randomized double-blinded controlled placebo study
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008


Randomized double-blind placebo-controlled trial of azithromycin in lung transplantation: first results
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008


Outcomes reported in pneumonia randomized controlled trials
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



The efficacy and safety of topical phenylephrine before flexible bronchoscopy: a double-blind, randomized controlled trial
Source: Annual Congress 2008 - News from diagnostic bronchoscopy
Year: 2008


A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019

Late Breaking Abstract - The impact of regular bisoprolol on recovery with salbutamol in asthma; a double-blind randomised controlled trial
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019